2005•Jilin yixueRequires access

The clinical research of Okra in treatment of diabetic nephropathy

Ying Zhang

Open publisher page 3 citations

Abstract

Objective To observe the clinical efficacies of Okra on diabetic nephropathy. Method 72 patients of diabetic nephropathy were randomly divided into control group (35 cases, traditional therapy) and treatment group (37 cases, traditional therapy+Okra),the duration was 6 months. Creatinine, blood uria nitrogen, triglyceride, total cholesterol, uric acid were determined in all the patients before and after the treatment. Results There was the obvious reduction in urine protein and uric acid of the treatment group (P0.05). There was no obvious change in plasma globulin and cholesterol between the treatment group and the control group. Conclusion Okra is a better efficient treatment agent for diabetic nephropathy.

About this research paper

What this paper is about

Objective To observe the clinical efficacies of Okra on diabetic nephropathy. Method 72 patients of diabetic nephropathy were randomly divided into control group (35 cases, traditional therapy) and treatment group (37 cases, traditional therapy+Okra),the duration was 6 months. Creatinine, blood uria nitrogen, triglyceride, total cholesterol, uric acid were determined in all the patients before and after the treatment. Results There was the obvious reduction in urine protein and uric acid of the treatment group (P0.05). There was no obvious change in plasma globulin and cholesterol between the treatment group and the control group. Conclusion Okra is a better efficient treatment agent for diabetic nephropathy.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical efficacies of Okra on diabetic nephropathy. Method 72 patients of diabetic nephropathy were randomly divided into control group (35 cases, traditional therapy) and treatment group (37 cases, traditional therapy+Okra),the duration was 6 months. Creatinine, blood uria nitrogen, triglyceride, total cholesterol, uric acid were determined in all the patients before and after the treatment. Results There was the obvious reduction in urine protein and uric acid of the treatment group (P0.05). There was no obvious change in plasma globulin and cholesterol between the treatment group and the control group. Conclusion Okra is a better efficient treatment agent for diabetic nephropathy.

Key concepts: Medicine, Uric acid, Creatinine, Diabetic nephropathy, Triglyceride, Internal medicine, Nephropathy, Diabetes mellitus

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical research of Okra in treatment of diabetic nephropathy — Research Paper | ScholarLens